OPUSPOINT PARTNERS

Their vision in forming Opus Point Partners and the Opus Point Healthcare Innovations Fund was to design a highly liquid, diversified strategy for investing in publicly-traded biotechnology and life science companies that could reproducibly over a long-term investment horizon generate exceptional returns. In many ways, it was a stark departure from their past, where their prior business activities naturally created illiquid and concentrated positions. Whether from being the founder of a Compan... y or the CEO, they were forced to accept unmitigated, un-hedged concentrated risk. Unlike investors in their Companies, they had limited ability to protect their investments from negative events, typically associated with biotechnology. The Innovations Fund takes advantage of their years of experience in the sector, targets area’s where they were successful in the past and avoids areas where they encountered failures. It compiles thousands of internal data points to identify the profile of the best investment opportunities and to avoid the pitfalls.